South Africa is a study in contrasts. And the 2026 public health agenda is no exception. Breakthrough HIV prevention medicine ...

Once exclusively a treatment for diabetes, GLP-1 medications have gone mainstream — forcing restaurants to adjust to changing ...

After a lackluster first half of 2025, healthcare stocks staged a comeback, posting the best performance among the 11 S&P 500 ...

Despite ushering in the current GLP-1 era, Novo Nordisk has fallen behind its chief rival Eli Lilly, which has exceeded the ...

Pharmaceutical companies have raised prices on hundreds of drugs so far this month despite federal efforts to rein in drug ...

Mason Newman was prescribed Mounjaro, a drug used in treating diabetes, which also suppresses appetite and can be combined ...

Here's what San Antonio doctors say about the widespread use of GLP-1 medications for obesity, diabetes and other conditions.

Shares of pharmaceutical giant Eli Lilly & Co. declined sharply following an unexpected regulatory update from the U.S. Food ...

Eli Lilly is getting its hands on a promising pipeline candidate thanks to an acquisition. The stock may not gain much more ...

A study previously carried out by Eli Lilly, the manufacturers of popular weight loss drug Mounjaro, found that of the 308 ...

Strive Specialities Inc., a major provider of compounded medicines, filed a federal lawsuit against pharmaceutical giants Eli ...

Canada is the first country that is preparing to approve lower-cost generic weight loss drugs. Mr. Funk was the managing ...